-
Loading metrics
Open Access
Peer-reviewed
Research Article
Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus
-
Pankaj Pal,
Affiliation Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Kimberly A. Dowd,
Affiliation Viral Pathogenesis Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
James D. Brien,
Affiliation Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Melissa A. Edeling,
Affiliation Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Sergey Gorlatov,
Affiliation MacroGenics, Rockville, Maryland, United States of America
⨯ -
Syd Johnson,
Affiliation MacroGenics, Rockville, Maryland, United States of America
⨯ -
Iris Lee,
Affiliation Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Wataru Akahata,
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Gary J. Nabel,
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Mareike K. S. Richter,
Affiliation Department of Medical Microbiology, Molecular Virology Section (HPC EB88), University Medical Center Groningen and University of Groningen, Groningen, Netherlands
⨯ -
Jolanda M. Smit,
Affiliation Department of Medical Microbiology, Molecular Virology Section (HPC EB88), University Medical Center Groningen and University of Groningen, Groningen, Netherlands
⨯ -
Daved H. Fremont,
Affiliations Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Theodore C. Pierson,
Affiliation Viral Pathogenesis Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Mark T. Heise,
Affiliation Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯ -
Michael S. Diamond
* E-mail: diamond@borcim.wustl.edu
Affiliations Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯
Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus
- Pankaj Pal,
- Kimberly A. Dowd,
- James D. Brien,
- Melissa A. Edeling,
- Sergey Gorlatov,
- Syd Johnson,
- Iris Lee,
- Wataru Akahata,
- Gary J. Nabel,
- Mareike K. S. Richter
- Published: April 18, 2013
- https://doi.org/10.1371/journal.ppat.1003312